The largest laboratory contract in the world was signed yesterday in Glasgow.
The contract, worth more than £100 million over seven years, will provide lab services across Greater Glasgow and Clyde with the necessary reagents to deliver diagnostic services for biochemistry, haematology, microbiology, genetics and pathology with clear financial and clinical benefits for the duration of the contact.
The contract with Abbott Diagnostics will also deliver the most advanced cutting edge technology including equipping the new super lab on the Southern General campus due to open in spring 2012.
This multi-million pound contract means rapid round the clock results with patient samples being processed even more quickly and efficiently.
Robert Calderwood, Chief Executive, NHS Greater Glasgow and Clyde said: “The importance of signing this contract with Abbott Laboratories cannot be underestimated.
“This is the largest laboratory contract in the world and we are delighted Abbott Diagnostics are being awarded this contract as they are world leaders in their field.
“Our clinical, technical and managerial staff have worked hard to ensure the multi-million pound contract, the first of its kind in the world, will deliver a managed service which will demonstrate clear financial and clinical benefits for the duration of the seven year contact.
Notes to editors
A reagent is a substance or compound that is added to a system in order to bring about a chemical reaction or is added to see if a reaction occurs.
The new super lab on the Southern General campus will cost £75 million and covers an area of approximately 25,000 square metres, over five storeys.
When open in 2012 it will be one of the most modern and efficient labs in the UK with approximately 700 staff from medical to biomedical scientists, technical assistants, administrative and clerical staff all working as a multi-disciplinary team.
For further information either telephone 0141 201 4429 or email email@example.com
Pic: Robert Calderwood, Chief Exexutive, NHSGGC (left) and Jeremy Schubert, General Manager, Abbott Diagnostics